SCHEMBL31228285

SCHEMBL31228285

CC(C)[C@@H](C(=O)OCC[Si](C)(C)C)N(C)C(=O)[C@H]1CCN(C(=O)OC(C)(C)C)[C@@H]1COCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 1/20 0.37
GHSR Q92847 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 2/20 0.36
PARP1 P09874 1/20 0.36
GPR119 Q8TDV5 2/20 0.35
GAA P10253 1/20 0.34
THRB P10828 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CMA1 P23946 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228241 0.90 YAP1 (0.39) KLK7GHSRMEN1KMT2AMAPT
SCHEMBL31228227 0.90 YAP1 (0.39) KLK7GHSRMEN1KMT2AMAPT
SCHEMBL31228531 0.89 KLK7 (0.39) KLK7GHSRKMT2APARP1GPR119
SCHEMBL31228368 0.84 MAPT (0.40) KLK7GHSRMEN1KMT2AMAPT
SCHEMBL31228461 0.84 ALDH1A1 (0.30) KMT2AALDH1A1
SCHEMBL31228393 0.80 KLK7 (0.44) KLK7GHSRMEN1KMT2AMAPT
SCHEMBL31228327 0.79
SCHEMBL31228493 0.77 KLK7 (0.46) KLK7KMT2APARP1GPR119SMN1; SMN2
SCHEMBL31228337 0.77 KLK7 (0.46) KLK7KMT2APARP1GPR119SMN1; SMN2
SCHEMBL31228495 0.77 KLK7 (0.46) KLK7KMT2APARP1GPR119SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688789-A1 MACROCYCLIC RAS INHIBITORS Revolution Medicines, Inc. (US) 2026-02-11 EP disclosed
WO-2024211663-A9 MACROCYCLIC RAS INHIBITORS Revolution Medicines, Inc. (US) 2025-01-30 WO disclosed
WO-2024211663-A1 CONDENSED MACROCYCLIC COMPOUNDS AS RAS INHIBITORS Revolution Medicines, Inc. (US) 2024-10-10 WO disclosed